Literature DB >> 29201878

Radiotherapy treatment strategies for squamous cell carcinoma of the cervical oesophagus: moving toward better outcomes.

Pierfrancesco Franco1, Francesca Arcadipane2, Paolo Strignano3, Renato Romagnoli4, Umberto Ricardi1.   

Abstract

Entities:  

Year:  2017        PMID： 29201878      PMCID： PMC5690974          DOI： 10.21037/atm.2017.08.16

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  9 in total

1.  Concurrent chemoradiation for patients with squamous cell carcinoma of the cervical esophagus.

Authors:  T Uno; K Isobe; H Kawakami; N Ueno; H Shimada; H Matsubara; S Okazumi; Y Nabeya; T Shiratori; T Kawata; T Ochiai; H Ito
Journal:  Dis Esophagus       Date:  2007       Impact factor: 3.429

2.  Intensity-modulated adjuvant whole breast radiation delivered with static angle tomotherapy (TomoDirect): a prospective case series.

Authors:  Pierfrancesco Franco; Michele Zeverino; Fernanda Migliaccio; Piera Sciacero; Domenico Cante; Valeria Casanova Borca; Paolo Torielli; Cecilia Arrichiello; Giuseppe Girelli; Gianmauro Numico; Maria Rosa La Porta; Santi Tofani; Umberto Ricardi
Journal:  J Cancer Res Clin Oncol       Date:  2013-09-14       Impact factor: 4.553

3.  Multicenter Phase 2 Study of Cisplatin and 5-Fluorouracil With Concurrent Radiation Therapy as an Organ Preservation Approach in Patients With Squamous Cell Carcinoma of the Cervical Esophagus.

Authors:  Sadamoto Zenda; Takashi Kojima; Ken Kato; Sachiko Izumi; Taijiro Ozawa; Naomi Kiyota; Chikatoshi Katada; Takahiro Tsushima; Yoshinori Ito; Tetsuo Akimoto; Yasuhisa Hasegawa; Miyuki Kanamaru; Hiroyuki Daiko
Journal:  Int J Radiat Oncol Biol Phys       Date:  2016-09-03       Impact factor: 7.038

4.  Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: an intergroup study.

Authors:  M al-Sarraf; K Martz; A Herskovic; L Leichman; J S Brindle; V K Vaitkevicius; J Cooper; R Byhardt; L Davis; B Emami
Journal:  J Clin Oncol       Date:  1997-01       Impact factor: 44.544

5.  Effect of Intensity Modulated Radiation Therapy With Concurrent Chemotherapy on Survival for Patients With Cervical Esophageal Carcinoma.

Authors:  Lachlan J McDowell; Shao Hui Huang; Wei Xu; Jiahua Che; Rebecca K S Wong; James Brierley; John Kim; Bernard Cummings; John Waldron; Andrew Bayley; Aaron Hansen; Ian Witterick; Jolie Ringash
Journal:  Int J Radiat Oncol Biol Phys       Date:  2017-01-09       Impact factor: 7.038

Review 6.  Pre-operative treatments for adenocarcinoma of the lower oesophagus and gastro-oesophageal junction: a review of the current evidence from randomized trials.

Authors:  Pierfrancesco Franco; Francesca Arcadipane; Paolo Strignano; Rosella Spadi; Elisabetta Trino; Stefania Martini; Giuseppe Carlo Iorio; Maria Antonietta Satolli; Mario Airoldi; Renato Romagnoli; Michele Camandona; Umberto Ricardi
Journal:  Med Oncol       Date:  2017-02-07       Impact factor: 3.064

7.  Management of Cervical Esophageal Carcinoma.

Authors: 
Journal:  Semin Radiat Oncol       Date:  1994-07       Impact factor: 5.934

Review 8.  Combined modality therapy for thoracic and head and neck cancers: a review of updated literature based on a consensus meeting.

Authors:  Pierfrancesco Franco; Alba Fiorentino; Francesco Dionisi; Michele Fiore; Silvia Chiesa; Stefano Vagge; Francesco Cellini; Luciana Caravatta; Mario Tombolini; Fiorenza De Rose; Icro Meattini; Gianluca Mortellaro; Giuseppina Apicella; Lorenza Marino; Daniela Greto
Journal:  Tumori       Date:  2016-07-02       Impact factor: 2.098

9.  Technical guidelines for head and neck cancer IMRT on behalf of the Italian association of radiation oncology - head and neck working group.

Authors:  Anna Merlotti; Daniela Alterio; Riccardo Vigna-Taglianti; Alessandro Muraglia; Luciana Lastrucci; Roberto Manzo; Giuseppina Gambaro; Orietta Caspiani; Francesco Miccichè; Francesco Deodato; Stefano Pergolizzi; Pierfrancesco Franco; Renzo Corvò; Elvio G Russi; Giuseppe Sanguineti
Journal:  Radiat Oncol       Date:  2014-12-29       Impact factor: 3.481
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.